Abstract | BACKGROUND: Improving cerebral perfusion remains a good option for ischemic stroke for restoring cerebral blood flow. Human urinary kallidinogenase has been shown promising in treating stroke patients. To investigate whether human urinary kallidinogenase's efficacy in treating stroke patients has relationship with improving cerebral perfusion and possible mechanism. METHODS: RESULTS: CONCLUSIONS:
|
Authors | Jingwei Li, Yan Chen, Xin Zhang, Bing Zhang, Meijuan Zhang, Yun Xu |
Journal | Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
(J Stroke Cerebrovasc Dis)
Vol. 24
Issue 8
Pg. 1730-7
(Aug 2015)
ISSN: 1532-8511 [Electronic] United States |
PMID | 26139453
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2015. Published by Elsevier Inc. |
Chemical References |
- Vascular Endothelial Growth Factor A
- Kallikreins
|
Topics |
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Disability Evaluation
- Female
- Humans
- Kallikreins
(metabolism, therapeutic use)
- Magnetic Resonance Angiography
- Male
- Middle Aged
- Prospective Studies
- Reperfusion
- Severity of Illness Index
- Statistics, Nonparametric
- Stroke
(complications, drug therapy)
- Time Factors
- Treatment Outcome
- Vascular Endothelial Growth Factor A
(metabolism)
- Young Adult
|